McKesson Corporation (LON:0JZU)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 65.61B |
| Revenue (ttm) | 277.90B |
| Net Income (ttm) | 2.55B |
| Shares Out | n/a |
| EPS (ttm) | 19.91 |
| PE Ratio | 25.73 |
| Forward PE | 18.69 |
| Dividend | 2.18 (0.31%) |
| Ex-Dividend Date | Jun 2, 2025 |
| Volume | 57 |
| Average Volume | 262 |
| Open | 700.00 |
| Previous Close | 691.28 |
| Day's Range | 691.65 - 700.00 |
| 52-Week Range | 466.12 - 738.00 |
| Beta | 0.48 |
| RSI | 35.04 |
| Earnings Date | Aug 6, 2025 |
About Aspen Technology
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt... [Read more]
Financial Performance
In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.
Financial StatementsNews
McKesson Corporation Raises Quarterly Dividend by 15% to $0.82 Per Share
IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.82 per share of common stock, a 15% increase from $0.71 per share ...
McKesson Defied The Doubters (Including Me)--And Could Do It Again
McKesson delivered strong double-digit growth in revenue, earnings, and free cash flow in fiscal 2025, outperforming the S&P 500 significantly. The planned spin-off of the underperforming Medical-Surg...
How Do Investors Really Feel About McKesson?
McKesson's (NYSE: MCK) short percent of float has risen 6.21% since its last report. The company recently reported that it has 2.13 million shares sold short , which is 1.71% of all regular shares th...
Our Top 10 High Growth Dividend Stocks - July 2025
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat...
McKesson ideaShare Empowers Independent Pharmacies to Innovate and Thrive
IRVING, Texas--(BUSINESS WIRE)--Last week, McKesson hosted more than 2,500 attendees representing independent pharmacies at the 2025 McKesson ideaShare conference in Nashville.
McKesson Corporation Announces First Quarter Fiscal 2026 Earnings Release Date
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will host a l...
Calls of the Day: ServiceNow, S&P Global, McKesson Corp., Ross Stores, TJX and Burlington
The Investment Committee debate the latest Calls of the Day.
Calls of the Day: ServiceNow, S&P Global, McKesson Corp., Ross Stores, TJX and Burlington
The Investment Committee debate the latest Calls of the Day.
Bargain Alert: I'm Buying Monthly Dividends Up To 7% Yield
Timing of income is an important consideration. Monthly dividend stocks provide recurring income and faster compounding of wealth. I highlight two monthly dividend payers that are undervalued while su...
Our Top 10 High Growth Dividend Stocks - June 2025
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat...
20 companies in the S&P 500 whose investors have gained the greatest rewards from stock buybacks
These companies have reduced their share counts the most over the past 10 years
Here's How Much $100 Invested In McKesson 20 Years Ago Would Be Worth Today
McKesson (NYSE: MCK) has outperformed the market over the past 20 years by 6.76% on an annualized basis producing an average annual return of 15.11%. Currently, McKesson has a market capitalization o...
Stan Wong's Top Picks: iShares Silver Bullion ETF, McKesson & Nvidia
Stan Wong, Portfolio Manager at Scotia Wealth Management, shares his top stock picks to watch in the market.
McKesson to Host Investor Day on September 23, 2025
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced it will host an Investor Day on Tuesday, September 23, 2025, in New York City. The event will feature presentations by McKess...
McKesson Corporation Completes Acquisition of Core Ventures
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that it has completed the acquisition of a controlling interest in Community Oncology Revitalization Enterprise Venture...
Here's How Much You Would Have Made Owning McKesson Stock In The Last 15 Years
McKesson (NYSE: MCK) has outperformed the market over the past 15 years by 4.95% on an annualized basis producing an average annual return of 16.79%. Currently, McKesson has a market capitalization o...
McKesson: Sustained Rally Backed By Strong Financials
Our Top 10 High-Growth Dividend Stocks -- May 2025
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat...
McKesson To Spin-Off Its Medical-Surgical Solutions Business
Deal OverviewOn May 8, 2025, McKesson Corporation (NYSE: MCK, $682.28, Market Capitalization: $85.4 billion), a diversified healthcare services company, announced its intention to separate its Medical...
In a vacuum, the McKesson quarter was strong enough to spark a rally for the stock, says Jim Cramer
'Mad Money' host Jim Cramer recaps latest action impacting drug distributor companies.
McKesson Corporation (MCK) CFO Britt Vitalone Hosts BofA Securities 2025 Healthcare Conference (Transcript)
Here's How Much $100 Invested In McKesson 15 Years Ago Would Be Worth Today
McKesson (NYSE: MCK) has outperformed the market over the past 15 years by 4.93% on an annualized basis producing an average annual return of 16.53%. Currently, McKesson has a market capitalization o...
Why McKesson Stock Bumped Modestly Higher Today
McKesson: Spin-Off Of Medical-Surgical Solutions Is A Positive, Strong Buy
McKesson is a Strong Buy with growth in oncology and biopharma, 19% revenue surge, and a focus on high-growth pharma markets. Read why MCK is a Strong Buy.